Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
11 Results for ''
Press Release
“Suspended animation” drug could aid organ transplantation and survival from traumatic injury
September 24, 2024
Press Release
Wyss Institute team selected by DARPA-SHIELD program to develop first-of-its-kind biologically engineered broad-spectrum antimicrobial therapeutic
September 16, 2024
Translation News
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
February 10, 2022
Press Release
A viable vaccine for tough tumors
November 10, 2020
Press Release
A solid vaccine for liquid tumors
January 14, 2020
Press Release
Helping transplanted stem cells stick around and do their jobs
July 15, 2019
Press Release
Hansjörg Wyss, Harvard M.B.A. ’65, Gives Unprecedented Third Major Gift to Harvard to Support the Wyss Institute’s Mission to Develop and Commercialize World-Changing Technologies
June 7, 2019
Press Release
A golden ticket to faster muscle recovery
October 1, 2018
Awards
Wyss Researcher Named 2017 STAT Wunderkind
October 13, 2017
Press Release
Sticky when wet: strong adhesive for wound healing
July 27, 2017
Press Release
Controlling bleeding disorders with fitted hydrogel casts
November 16, 2016
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
